Buscar en RiuNet

Listar

Todo RiuNet

Mi cuenta

Acceder

Ayuda RiuNet

Admin. UPV

Listar por palabra clave "VEGF"

Mostrando ítems 1-5 de 5

Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC

Jantus Lewintre, Eloisa; Sanmartin, Elena; Sirera Pérez, Rafael; Blasco, Ana; Sanchez, Jose Javier; Taron, Miguel; Rosell, Rafael; Camps, Carlos (Elsevier, 2011-11)

Introduction: The vascular endothelial growth factor (VEGF) family of ligands and receptors (VEGFR) play an important role in tumor angiogenesis. Increased expression of angiogenic factors in tumors or in blood is associated ...
Engineered microenvironments for synergistic VEGF - Integrin signalling during vascularization

Moulisova, Vladimira; González García, Cristina; Cantini, Marco; Rodrigo Navarro, Aleixandre; Weaver, Jessica; Costell, Mercedes; Sabater i Serra, Roser; Dalby, Matthew J.; García, Andrés J.; Salmerón Sánchez, Manuel (Elsevier, 2017)

[EN] We have engineered polymer-based microenvironments that promote vasculogenesis both in vitro and in vivo through synergistic integrin-growth factor receptor signalling. Poly(ethyl acrylate) (PEA) triggers spontaneous ...
Phase II clinical trial with gemcitabine and paclitaxel sequential monotherapy as first-line treatment for advanced non-small-cell lung cancer (SLCG 01-04)

Iranzo, Vega; Sirera Pérez, Rafael; Carrato, Alfredo; Cabrera, Andrea; Jantus, Eloísa; Guijarro, Ricardo; Sanmartín, Elena; Blasco, Ana; Gil, Mireia; Gómez Aldaraví, Lorenzo; González Larriba, José Luis; Massuti, Bertomeu; Velasco, Amalia; Provencio, Mariano; Rosell, Rafael; Camps, Carlos (Springer, 2011-06)

[EN] Background: In advanced-stage (IIIB or IV) non-small-cell lung cancer (NSCLC), combination chemotherapy has demonstrated response rates of 20% and a 1-year survival rate of 30%. We conducted a multicentre, open-label, ...
Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study

Jantus-Lewintre, Eloisa; Massuti Sureda, Bartomeu; Gonzalez Larriba, Jose Luis; Rodríguez-Abreu, Delvys; Juan, Oscar; Blasco, Ana; Domine, Manuel; Provencio Pulla, Mariano; Garde, Javier; Alvarez, Rosa; Maestu, Inmaculada; Perez de Carrion, Ramon; Artal, Angel; Rolfo, Christian; de Castro, Javier; Camps, Carlos (Frontiers Media SA, 2021-07-26)

[EN] Finding angiogenic prognostic markers in advanced non-small-cell lung cancer is still an unmet medical need. We explored a set of genetic variants in the VEGF-pathway as potential biomarkers to predict clinical outcomes ...
Simultaneous boron ion-channel/growth factor receptor activation for enhanced vascularization

Rico Tortosa, Patricia María; Rodrigo Navarro, Aleixandre; La Peña Del Rivero, Marcos De; Moulisova, Vladimira; Costell, Mercedes; Salmerón Sánchez, Manuel (John Wiley & Sons, 2018-10-30)

[EN] Boron ion is essential in metabolism and its concentration is regulated by ion-channel NaBC1. NaBC1 mutations cause corneal dystrophies such as Harboyan syndrome. Here we propose a 3D molecular model for NaBC1 and ...

Mostrando ítems 1-5 de 5

Listar por palabra clave "VEGF"

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Buscar en RiuNet

Listar

Todo RiuNet

Mi cuenta

Ayuda RiuNet

Admin. UPV

Listar por palabra clave "VEGF"